CAS 136310-95-7

Tiotropium Related Compound C ((1R,3s,5S)-3-[2-Hydroxy-2,2-di(thiophen-2-yl)acetoxy]-8,8-dimethyl-8-azabicyclo[3.2.1]oct-6-en-8-ium bromide)

CAS: 136310-95-7

Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi

Formula: C₁₉H₂₂BrNO₃S₂

Color and Shape: White Yellow Powder

Molecular weight: 455.02245

Ref: 45-1667619

Tiotropium Bromide EP Impurity C Bromide

CAS: 136310-95-7

Formula: C₁₉H₂₂NO₃S₂·Br

Color and Shape: Off-White Solid

Molecular weight: 376.51 79.90

Ref: 4Z-T-329

(1R,3s,5S)-3-(2-Hydroxy-2,2-di(thiophen-2-yl)acetoxy)-8,8-dimethyl-8-azabicyclo[3.2.1]oct-6-en-8-ium bromide (Tiotropium Bromide Impurity)

CAS: 136310-95-7

(1R,3s,5S)-3-(2-Hydroxy-2,2-di(thiophen-2-yl)acetoxy)-8,8-dimethyl-8-azabicyclo[3.2.1]oct-6-en-8-ium bromide (Tiotropium Bromide Impurity)

Purity: 98%

Ref: 54-OR1076474

(1R,3S,5S)-3-(2-Hydroxy-2,2-di(thiophen-2-yl)acetoxy)-8,8-dimethyl-8-azabicyclo[3.2.1]oct-6-en-8-ium Bromide

Controlled Product

CAS: 136310-95-7

Impurity Tiotropium bromide EP impurity C
Applications (1R,3S,5S)-3-(2-Hydroxy-2,2-di(thiophen-2-yl)acetoxy)-8,8-dimethyl-8-azabicyclo[3.2.1]oct-6-en-8-ium Bromide is an impurity in the synthesis of Tiotropium Bromide (T444850), a muscarinic receptor antagonist. Bronchodilator.
References Haddad, E.-B., et al.: Mol. Pharmacol., 45, 899 (1994); Donohue, J. F., et al.: Chest, 122, 47 (2002); Profita, M., et al.: Allergy, 60, 1361 (2005); Dusser, D., et al.: Eur. Respir. J., 27, 547 (2006);

Formula: C₁₉H₂₂NO₃S₂·Br

Color and Shape: Neat

Molecular weight: 456.42

Ref: TR-H941715

(1R,3S,5S)-3-(2-Hydroxy-2,2-di(thiophen-2-yl)acetoxy)-8,8-dimethyl-d3-8-azabicyclo[3.2.1]oct-6-en-8-ium Bromide

Controlled Product

CAS: 136310-95-7

Applications (1R,3S,5S)-3-(2-Hydroxy-2,2-di(thiophen-2-yl)acetoxy)-8,8-dimethyl-d3-8-azabicyclo[3.2.1]oct-6-en-8-ium Bromide is the labeled analogue of (1R,3S,5S)-3-(2-Hydroxy-2,2-di(thiophen-2-yl)acetoxy)-8,8-dimethyl-8-azabicyclo[3.2.1]oct-6-en-8-ium Bromide (H941715), an impurity in the synthesis of Tiotropium Bromide (T444850), a muscarinic receptor antagonist. Bronchodilator.
References Haddad, E.-B., et al.: Mol. Pharmacol., 45, 899 (1994); Donohue, J. F., et al.: Chest, 122, 47 (2002); Profita, M., et al.: Allergy, 60, 1361 (2005); Dusser, D., et al.: Eur. Respir. J., 27, 547 (2006);

Formula: C₁₉D₃H₁₉NO₃S₂·Br

Color and Shape: Neat

Molecular weight: 459.435

Ref: TR-H941717

(1R,3S,5S)-3-(2-Hydroxy-2,2-di(thiophen-2-yl)acetoxy)-8,8-dimethyl-8-azabicyclo[3.2.1]oct-6-en bromide

CAS: 136310-95-7

The human red blood cell (RBC) is a non-nucleated cell in the human blood that carries oxygen to the body's cells. The erythrocyte is characterized by its biconcave shape and its lack of organelles. It has a volume of about 80 fL, and a diameter of about 7 micrometers. The RBCs are produced in bone marrow from precursor cells that differentiate into erythroid progenitor cells. This drug binds to the hemoglobin molecules in the red blood cells and alters their shape, causing an increase in their deformability. In addition, this drug decreases the viscosity of the plasma outside of the red blood cell, which increases its extravascular sensitivity. Evaluations have been performed on low doses to evaluate sensitivities within capillaries with microscopy parameters such as magnification and resolution. These evaluations have shown that this drug can be used for quantifying changes in capillary size due to low doses (

Formula: C₁₉H₂₂NO₃S₂·Br

Purity: Min. 95%

Molecular weight: 456.42 g/mol

Ref: 3D-IH42882

Tiotropium EP Impurity C

CAS: 136310-95-7

Formula: C₁₉H₂₂NO₃S₂Br

Molecular weight: 376.51 : 79.9

Ref: ST-EA-CP-T22003